Renji Hospital Gastroenterology: Endoscopy and IBD Teams

What the department is and how it is organised

Renji Hospital is a Shanghai teaching hospital associated with Shanghai Jiao Tong University School of Medicine. Its official gastroenterology introduction dates the department's foundation to 1984 under Jiang Shaoji and Xiao Shudong. The page records Ministry of Education key-discipline, health-authority key-laboratory and national clinical-key-specialty recognition, placing its clinical work within an academic and research setting.

The department's directions include early gastrointestinal cancer detection and endoscopic treatment, complex inflammatory bowel disease, Helicobacter pylori, autoimmune liver disease, and functional or psychosomatic digestive disorders. These are different assessment questions rather than interchangeable labels. A previously identified polyp, an unsettled colitis diagnosis and unexplained liver-test results call for different descriptions of what another opinion is meant to resolve.

Renji placed first in gastroenterology in the Fudan 2023 national specialty reputation list. This historical departmental reference does not separately rank its subspecialties or individual clinicians.

Early GI cancer detection and endoscopic treatment

Early gastrointestinal neoplasia and endoscopic management form a documented clinical direction. For a person who already has a finding from an earlier endoscopy, the important question is what that finding means for the next decision. Ask whether the existing report and images are sufficient to discuss endoscopic treatment, or whether the team would first need to clarify the diagnosis.

Li Xiaobo's May 2024 official biography identifies him as gastroenterology deputy director and digestive endoscopy centre director, with a focus on gastrointestinal neoplasia and polyps. It describes endoscopic mucosal resection, endoscopic submucosal dissection and narrow-band imaging, as well as endoscopy atlases, early-cancer diagnostic manuals and classification-software work. The profile records his contribution as sixth participant to a National Science and Technology Progress Second Prize for gastrointestinal cancer warning, prevention and mechanisms; no award year is inferred.

These interests connect lesion assessment with the question of how an endoscopic approach would be chosen. If more than one recommendation has been offered, retain the original reports and ask the reviewing clinician to explain the difference between them. A technique appearing in a clinician's biography is not enough to establish that it is appropriate for the lesion in question.

Inflammatory bowel disease and Helicobacter pylori care

Complex inflammatory bowel disease and Helicobacter pylori are separately listed clinical directions. An IBD enquiry might ask whether an existing diagnosis or treatment proposal warrants review; a Helicobacter-related enquiry should identify the actual finding and previous care rather than assume the same pathway. The department introduction documents scope, not a personal treatment protocol.

For someone living abroad, continuity is an important question to settle before travel. Ask what part of the current plan the team could assess, which existing records it would request, and how a recommendation would be communicated to the clinician providing ongoing care. Any examination or additional investigation remains an individual clinical decision, not a requirement inferred from the hospital's reputation.

A concise chronology can distinguish a new question from a request to review earlier decisions: when was the diagnosis made, which recommendations have already been discussed, and what remains unresolved? Ask whether the available endoscopy, pathology or treatment records answer the team's questions before arranging more tests. Keeping dates attached to previous records is more informative than sending isolated findings without their context.

Autoimmune liver disease and functional digestive disorders

Autoimmune liver disease is another direction identified by Renji's department introduction. For an enquiry, describe whether the question concerns a possible diagnosis, interpretation of an earlier assessment or review of a continuing plan. Ask which already available reports the clinician would need, instead of treating an article's disease list as a recommendation for particular tests or medicines.

Functional and psychosomatic gastrointestinal disorders form a different part of the department's documented scope. Someone asking about persistent symptoms can state what has already been investigated and what question remains unanswered, without assuming that a particular diagnosis applies. Ask whether the receiving team is the appropriate service for that question and what assessment would be needed before it could advise.

This distinction also matters when several issues appear in one file. Are the liver-related findings and digestive symptoms part of the same question, or are separate opinions being requested? That is a question for clinical review, not something a coordination service can settle. A focused summary can preserve both concerns without presenting them as a single established diagnosis.

Fang Jingyuan, Zeng Minde and dated professional honours

Shanghai Jiao Tong University's announcement of 19 September 2022 records Fang Jingyuan receiving the fourteenth Tan Jiazhen Life Science Award in the Clinical Medicine category at the September 17 ceremony. The report describes his contributions to disease causes, diagnosis, treatment and prognosis. It identifies him as hospital vice president and gastroenterology director at that time; those are dated roles, not independently verified current appointments.

Renji's 14 November 2024 announcement names Zeng Minde as a Medical Ethics Light honoree and Fang Jingyuan as a Medical Ethics Model honoree in Shanghai's third selection. It associates Fang's work with gastrointestinal cancer and precancerous disease, including microbiome and repurposed-medicine research. The recognition concerns professional contribution and conduct, while the research is not a prescribing recommendation or a guarantee of cancer prevention.

These examples give the department's honours identifiable recipients and dates. Li Xiaobo's endoscopy-related contribution, Fang's clinical-science recognition and the medical-ethics honours describe different achievements. They should not be merged into a single claim that all clinicians have the same specialty, nor used to decide who should assess a patient's file without considering the clinical question.

Aging, chronic liver disease and translational research

Renji's Institute of Aging and Tissue Repair was created in 2023. A May 2024 hospital description brings together clinical and basic-science work in aging-related cancer and chronic liver disease, with Ma Xiong among the recruited principal investigators. This adds a research connection to clinical gastroenterology; it does not establish that Ma is the gastroenterology department director.

Research into tissue repair and disease mechanisms is distinct from an available treatment. The institute's existence does not establish an offer of regenerative or experimental therapy. If a proposed intervention is described using those terms, ask the treating institution to identify its clinical status, the evidence relevant to the case and whether it is routine care or research.

For a patient reading a research report, the useful distinction is between the scientific question and the decision being faced now. Is the enquiry about understanding a difficult diagnosis, reviewing an established treatment proposal, or asking about a research opportunity? State that aim explicitly. A research platform can explain academic interests, but access and suitability require separate confirmation.

Practical decisions before you enquire

Before making travel plans, ask what can be assessed from the existing records, which uncertainties require an in-person visit, and how any recommendations would reach the doctors providing follow-up at home. Confirm the proposed assessment and its charges in writing. The hospital's departmental profile alone cannot confirm an appointment, admission or an individual treatment offer.

ChinaSpecialistCare can help shape a focused digestive-disease enquiry, organise the records requested for assessment and coordinate appointments and interpretation where available. We work independently of the hospital and cannot guarantee acceptance or a named clinician. An initial enquiry is free; the treating team determines clinical suitability and the next steps.

Digestive disease care in China

Sources & scope of this guide

References and official service information relevant to this guide.

This is general planning information and has not been individually reviewed by a doctor. Medical decisions and personal treatment advice come from your treating clinicians.